Search results
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO...
Simply Wall St. via Yahoo Finance· 4 days ago(NASDAQ:MRNA) have been quite disappointing recently and CEO Stephane Bancel bears some...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 2 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe company reaffirmed anticipated revenue of $4bn from its respiratory franchise. It now expects around $0.3bn in net sales for the first half of the...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 2 days ago“This is the start of a banner year for our vaccine platform as we continue to advance mRNA...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 23 hours agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 2 days agoModerna reported first-quarter financial results Thursday that soundly beat Wall Street...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 2 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 2 days agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 ...
Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fall By Investing.com
Investing.com· 2 days agoModerna Inc. (NASDAQ:MRNA) reported first-quarter earnings and revenue that came ahead of analyst...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 2 days agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...